This inventor holds 1 USPTO granted patent. Top assignees: Neurolixis, University of California. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 3 
1 out of 16,048 
Years Active: 2024
Title: The Innovative Contributions of Xin Tao
Introduction
Xin Tao is a notable inventor based in Riverside, CA, who has made significant strides in the field of medical research. With a focus on treating diseases associated with sudden unexpected death in epilepsy, her work has the potential to impact many lives.
Latest Patents
Xin Tao holds a patent for the "Use of serotonin 5-HT1A receptor agonists to treat diseases associated with sudden unexpected death in epilepsy." This patent addresses the treatment and prevention of conditions such as Fragile X syndrome by administering a selective 5-HT1A receptor agonist. The innovative approach aims to reduce the risks associated with these serious health issues.
Career Highlights
Throughout her career, Xin Tao has worked with prominent organizations, including Neurolixis and the University of California. Her contributions to these institutions have been instrumental in advancing research in her field.
Collaborations
Xin Tao has collaborated with esteemed colleagues such as Adrian Newman-Tancredi and Mark Andrew Varney. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Xin Tao's work exemplifies the spirit of innovation in medical research, particularly in addressing critical health challenges. Her contributions through patents and collaborations highlight her commitment to improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile